{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:12:42Z","timestamp":1790421162662,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.schres.2017.09.043","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T20:18:37Z","timestamp":1506716317000},"page":"252-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Pregnancy exposure to quetiapine \u2013 Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4198-5160","authenticated-orcid":false,"given":"Michael","family":"Paulzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamme W.","family":"Goecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Kuzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-0307","authenticated-orcid":false,"given":"Marc","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.09.043_bb0005","series-title":"Wilson's Six Principles of Teratology Embryo Project Encyclopedia","author":"Aston","year":"2014"},{"issue":"6","key":"10.1016\/j.schres.2017.09.043_bb0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0188-4409(02)00403-4","article-title":"Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol","volume":"33","author":"Atmaca","year":"2002","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.schres.2017.09.043_bb0015","doi-asserted-by":"crossref","first-page":"e7085","DOI":"10.1136\/bmj.e7085","article-title":"Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study","volume":"345","author":"Boden","year":"2012","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.schres.2017.09.043_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archgenpsychiatry.2011.1870","article-title":"Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects","volume":"69","author":"Boden","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.09.043_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1176\/appi.ajp.2015.15040506","article-title":"Reproductive safety of second-generation antipsychotics: current data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics","volume":"173","author":"Cohen","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2017.09.043_bb0030","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.psy.0000244025.20549.bd","article-title":"Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort study among women with early and regular care","volume":"68","author":"Dayan","year":"2006","journal-title":"Psychosom. Med."},{"issue":"1","key":"10.1016\/j.schres.2017.09.043_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.earlhumdev.2008.07.002","article-title":"Prenatal depression restricts fetal growth","volume":"85","author":"Diego","year":"2009","journal-title":"Early Hum. Dev."},{"issue":"4","key":"10.1016\/j.schres.2017.09.043_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bcpt.12372","article-title":"Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review","volume":"116","author":"Ennis","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.schres.2017.09.043_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2174\/138920111795470877","article-title":"Drug transport across the placenta","volume":"12","author":"Eshkoli","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"2","key":"10.1016\/j.schres.2017.09.043_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/2042098614522682","article-title":"Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects","volume":"5","author":"Galbally","year":"2014","journal-title":"Ther. Adv. Drug Saf."},{"issue":"2","key":"10.1016\/j.schres.2017.09.043_bb0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(24)39087-1","article-title":"Placental transporters relevant to drug distribution across the maternal-fetal interface","volume":"294","author":"Ganapathy","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.schres.2017.09.043_bb0060","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1517\/17425255.2012.699041","article-title":"Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier","volume":"8","author":"Giaginis","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"10","key":"10.1016\/j.schres.2017.09.043_bb0065","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","article-title":"A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction","volume":"67","author":"Grote","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.09.043_bb0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","article-title":"Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study","volume":"33","author":"Habermann","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.09.043_bb0075","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","author":"Hiemke","year":"2017","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.09.043_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.schres.2017.09.043_bb0085","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic use in pregnancy and the risk for congenital malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiat."},{"issue":"3","key":"10.1016\/j.schres.2017.09.043_bb0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(16)00003-1","article-title":"Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15year findings from a UK national inquiry","volume":"3","author":"Khalifeh","year":"2016","journal-title":"The Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2017.09.043_bb0095","doi-asserted-by":"crossref","first-page":"e94788","DOI":"10.1371\/journal.pone.0094788","article-title":"A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies","volume":"9","author":"Kulkarni","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.schres.2017.09.043_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","article-title":"Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?","volume":"116","author":"Lin","year":"2010","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2017.09.043_bb0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/070674371005500607","article-title":"The relation between maternal schizophrenia and low birth weight is modified by paternal age","volume":"55","author":"Lin","year":"2010","journal-title":"Can. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.09.043_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study","volume":"66","author":"McKenna","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"5 Pt 1","key":"10.1016\/j.schres.2017.09.043_bb0115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1399-5618.2006.00350.x","article-title":"Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania","volume":"8","author":"Nasrallah","year":"2006","journal-title":"Bipolar Disord."},{"issue":"8","key":"10.1016\/j.schres.2017.09.043_bb0120","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes","volume":"164","author":"Newport","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2017.09.043_bb0125","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3109\/00048674.2011.566547","article-title":"Placental transfer of aripiprazole","volume":"45","author":"Nguyen","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.09.043_bb0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/chromsci\/bms001","article-title":"Validated LC-MS-MS method for the determination of quetiapine in human plasma: application to a pharmacokinetic study","volume":"50","author":"Pan","year":"2012","journal-title":"J. Chromatogr. Sci."},{"issue":"3","key":"10.1016\/j.schres.2017.09.043_bb0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/JCP.0000000000000308","article-title":"Suicide attempt during late pregnancy with quetiapine: nonfatal outcome despite severe intoxication","volume":"35","author":"Paulzen","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.schres.2017.09.043_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YIC.0000000000000088","article-title":"Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood","volume":"30","author":"Paulzen","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.09.043_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.01.019","article-title":"Sertraline in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"212","author":"Paulzen","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"Pt B","key":"10.1016\/j.schres.2017.09.043_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pnpbp.2017.06.030","article-title":"Pregnancy exposure to citalopram - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"79","author":"Paulzen","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.09.043_bb0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00213-013-3060-6","article-title":"Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study","volume":"228","author":"Peng","year":"2013","journal-title":"Psychopharmacology"},{"issue":"5\u20136","key":"10.1016\/j.schres.2017.09.043_bb0160","first-page":"179","article-title":"Interleukin-6 as diagnostic marker for neonatal sepsis: determination of Access IL-6 cutoff for newborns","volume":"54","author":"Prinsen","year":"2008","journal-title":"Clin. Lab."},{"issue":"7","key":"10.1016\/j.schres.2017.09.043_bb0165","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0269881106074065","article-title":"Placental transfer of quetiapine in relation to P-glycoprotein activity","volume":"21","author":"Rahi","year":"2007","journal-title":"J. Psychopharmacol."},{"issue":"3\u20134","key":"10.1016\/j.schres.2017.09.043_bb0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s13318-010-0021-x","article-title":"Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term","volume":"35","author":"Reimers","year":"2011","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.schres.2017.09.043_bb0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome","volume":"28","author":"Reis","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.schres.2017.09.043_bb0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hup.599","article-title":"Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6months of treatment for major depression","volume":"19","author":"Reis","year":"2004","journal-title":"Hum. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.schres.2017.09.043_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003062","article-title":"Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study","volume":"3","author":"Sadowski","year":"2013","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.schres.2017.09.043_bb0190","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.v69n0419","article-title":"Changes in antidepressant metabolism and dosing across pregnancy and early postpartum","volume":"69","author":"Sit","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2017.09.043_bb0195","first-page":"CD000967","article-title":"Quetiapine for schizophrenia","volume":"2","author":"Srisurapanont","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.schres.2017.09.043_bb0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF01967827","article-title":"Effects of drug administration in pregnancy on children's school behaviour","volume":"12","author":"Stika","year":"1990","journal-title":"Pharmaceutisch Weekblad. Scientific Edition"},{"issue":"2","key":"10.1016\/j.schres.2017.09.043_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","article-title":"Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001\u20132007: a population-based study of 585,615 deliveries","volume":"16","author":"Toh","year":"2013","journal-title":"Arch. Womens Ment. Health"},{"issue":"2","key":"10.1016\/j.schres.2017.09.043_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00007691-199103000-00016","article-title":"The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol","volume":"13","author":"Uematsu","year":"1991","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.schres.2017.09.043_bb0215","first-page":"640.e7-9","article-title":"Are major depression and generalized anxiety disorder associated with intrauterine growth restriction in pregnant women? A case-control study","volume":"33","author":"Uguz","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2017.09.043_bb0220","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.jp.7211290","article-title":"Amniotic fluid: not just fetal urine anymore","volume":"25","author":"Underwood","year":"2005","journal-title":"J Perinatol: official journal of the California Perinatal Association"},{"issue":"5","key":"10.1016\/j.schres.2017.09.043_bb0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0b013e3181f15849","article-title":"Treatment options for bipolar depression: a systematic review of randomized, controlled trials","volume":"30","author":"Vieta","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.09.043_bb0230","doi-asserted-by":"crossref","first-page":"h2298","DOI":"10.1136\/bmj.h2298","article-title":"Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study","volume":"350","author":"Vigod","year":"2015","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.schres.2017.09.043_bb0235","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation","volume":"164","author":"Viguera","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.09.043_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00737-008-0044-3","article-title":"Atypical antipsychotic use in pregnancy: a retrospective review","volume":"12","author":"Wichman","year":"2009","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.schres.2017.09.043_bb0245","series-title":"Environment and Birth Defects","author":"Wilson","year":"1973"},{"issue":"5","key":"10.1016\/j.schres.2017.09.043_bb0250","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/JCP.0000000000000171","article-title":"Perinatal use of aripiprazole: plasma levels, placental transfer, and child outcome in 3 new cases","volume":"34","author":"Windhager","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2017.09.043_bb0255","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","article-title":"Management of bipolar disorder during pregnancy and the postpartum period","volume":"161","author":"Yonkers","year":"2004","journal-title":"Am. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417306059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417306059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:23:47Z","timestamp":1750893827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417306059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":51,"alternative-id":["S0920996417306059"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.09.043","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy exposure to quetiapine \u2013 Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.09.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}